ATI Gets $450M Army Contract Modification for Coronavirus Antibody Production

ATI Gets $450M Army Contract Modification for Coronavirus Antibody Production
ATI

Advanced Technology International has been awarded a one-year, $450.4M contract modification by the U.S. Army to produce antibodies to the virus that causes COVID-19.

The branch obligated the full contract amount for ATI’s large-scale antibody manufacturing efforts, the Department of Defense said Tuesday.

Work will take place in Summerville, S.C., and Tarrytown, N.Y., through June 30 next year.

ATI operates as a nonprofit subsidiary of ANSER and serves government customers through research-and-development collaboratins.

Check Also

Norm Tew VP and GM Boeing

Boeing Submits Bid for Next-Generation Interceptor Program; Norm Tew Quoted

Boeing (NYSE: BA) has submitted its proposal for the Missile Defense Agency’s Next-Generation Interceptor program and offered a design that builds on the company's six decades of experience in weapons systems and strategic missile development.

AI

Deloitte to Help DoD Create AI Dev’t Environment Under $106M Task Order

Deloitte Consulting has received a potential four-year, $106.4M task order to provide a development environment for the Department of Defense's Joint Artificial Intelligence Center to test, validate and implement AI-based tools.